Literature DB >> 12408448

Probiotics and Helicobacter pylori eradication.

F Canducci1, F Cremonini, A Armuzzi, S Di Caro, M Gabrielli, L Santarelli, E Nista, A Lupascu, D De Martini, A Gasbarrini.   

Abstract

The need for new strategies for Helicobacter pylori eradication, alternative or complementary to antibiotic therapy, has recently claimed the attention of many investigators. Pre-clinical studies have shown the inhibition of Helicobacter pylori growth by Lactobacilli and the anti-Helicobacter pylori action of Lactobacillus salivarius, Lactobacillus acidophilus and Lactobacillus casei subspecies rhamnosus strains, possibly due to the production of lactic acid or to the secretion of an autolysin. Clinical studies have demonstrated a persistent reduction in delta over baseline values at the 13C urea breath test independently of omeprazole administration with Lactobacillus acidophilus La1, the eradication in 6 out of 14 patients with Lactobacillus acidophilus alone, positive results in patients in which a standard Helicobacter pylori triple therapy was randomly supplemented with Lactobacillus acidophilus.

Entities:  

Mesh:

Year:  2002        PMID: 12408448     DOI: 10.1016/s1590-8658(02)80172-4

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  11 in total

Review 1.  Eradication of Helicobacter pylori: a clinical update.

Authors:  Marco Romano; Antonio Cuomo
Journal:  MedGenMed       Date:  2004-02-17

2.  Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.

Authors:  J A da Silva Medeiros; T M F O Gonçalves; L Boyanova; M I de Correia Pereira; J N da Silva Paiva de Carvalho; A M de Sousa Pereira; A M Silvério Cabrita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-05       Impact factor: 3.267

3.  Characterization and Antibacterial Activity Against Helicobacter pylori of Lactic Acid Bacteria Isolated from Thai Fermented Rice Noodle.

Authors:  Sujitra Techo; Wonnop Visessanguan; Ratha-Korn Vilaichone; Somboon Tanasupawat
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

4.  Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori.

Authors:  E Chenoll; B Casinos; E Bataller; P Astals; J Echevarría; J R Iglesias; P Balbarie; D Ramón; S Genovés
Journal:  Appl Environ Microbiol       Date:  2010-12-17       Impact factor: 4.792

5.  Evaluation of the potential inhibitory activity of a combination of L. acidophilus, L. rhamnosus and L. sporogenes on Helicobacter pylori: A randomized double-blind placebo-controlled clinical trial.

Authors:  Chien-Ying Lee; Hung-Che Shih; Min-Chien Yu; Ming-Yung Lee; Ya-Lan Chang; Ya-Yun Lai; Yi-Ching Lee; Yu-Hsiang Kuan; Chun-Che Lin
Journal:  Chin J Integr Med       Date:  2016-10-19       Impact factor: 1.978

6.  Pseudomonas aeruginosa Inhibition of Flagellin-activated NF-kappaB and interleukin-8 by human airway epithelial cells.

Authors:  Jose Pena; Zhu Fu; Christian Schwarzer; Terry E Machen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 7.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

8.  Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus).

Authors:  M A Diaz; E M Bik; K P Carlin; S K Venn-Watson; E D Jensen; S E Jones; E P Gaston; D A Relman; J Versalovic
Journal:  J Appl Microbiol       Date:  2013-08-01       Impact factor: 3.772

9.  In vitro antagonistic activity of Lactobacillus casei against Helicobacter pylori.

Authors:  Shymaa Enany; Salah Abdalla
Journal:  Braz J Microbiol       Date:  2015-10-27       Impact factor: 2.476

Review 10.  Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases.

Authors:  Natallia V Varankovich; Michael T Nickerson; Darren R Korber
Journal:  Front Microbiol       Date:  2015-07-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.